Conditions: Neoplasms
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 30
Healthy volunteers: no

Brief summary:
The primary objective of the current study is to investigate the Maximum Tolerated Dose (MTD) in terms of safety and tolerability of BI 6727 in combination with fixed dose BIBF 1120, in patients with advanced or metastatic solid tumours.

Detailed description:

Arms:
arm 1: Finding Maximum Tolerated Dose of BI 6727 in combination with BIBF 1120

Interventions: intervention 1: BI 6727 intervention 2: BIBF 1120
Intervention descriptions: intervention 1: intravenous each 21 days intervention 2: oral continuously

Protocol document: